Otiflox 0.3%/0.025%/1% Ear Drop Information
Otiflox 0.3%/0.025%/1% Ear Drop is a prescription drug, available for use as Drops. Other than this, Otiflox 0.3%/0.025%/1% Ear Drop has some other therapeutic uses, which have been discussed ahead.
The optimal dosage of Otiflox 0.3%/0.025%/1% Ear Drop is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Otiflox 0.3%/0.025%/1% Ear Drop as well, which are listed below. Such side effects of Otiflox 0.3%/0.025%/1% Ear Drop normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, Otiflox 0.3%/0.025%/1% Ear Drop's effect is Safe during pregnancy and Safe for lactating mothers. Further, the section on Otiflox 0.3%/0.025%/1% Ear Drop related warnings talks about Otiflox 0.3%/0.025%/1% Ear Drop's effects on the liver, heart and kidney.
Otiflox 0.3%/0.025%/1% Ear Drop can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Otiflox 0.3%/0.025%/1% Ear Drop in conditions like Atrial Fibrillation, Heart Failure, Myasthenia Gravis (MG). Some other conditions that can be affected by Otiflox 0.3%/0.025%/1% Ear Drop are listed in the contraindications section below.
Additionally, Otiflox 0.3%/0.025%/1% Ear Drop may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that Otiflox 0.3%/0.025%/1% Ear Drop is safe while driving, and is is addictive in nature.
Otiflox 0.3%/0.025%/1% Ear Drop Benefits & Uses
Otiflox 0.3%/0.025%/1% Ear Drop is used to treat the following -
Other Benefits
- Ear Infection (Read More - Fast and Natural Ways to Cure Ear Infections at Home)
- Ear canal infection
Otiflox 0.3%/0.025%/1% Ear Drop Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Adult |
|
| Geriatric |
|
Otiflox 0.3%/0.025%/1% Ear Drop Side Effects
Based on research, the following side effects have been observed when Otiflox 0.3%/0.025%/1% Ear Drop is used -
Severe
- Allergic reaction
- Cough
- Visual Disturbance
Moderate
- Constipation (Read More - Home remedies for constipation)
- Vaginal inflammation
- Hepatitis
- Jaundice (Read More - Home Remedies for Jaundice)
- Skin Thinning
- Electrolyte imbalance
- Bone degradation
- Increased blood pressure
- Skin scar
- Altered bone growth
- Behavioural Changes
- Increased Glucose level in the blood
- Cataract
Mild
- Nausea or vomiting
- Diarrhoea
- Polyuria
- Rash
- Insomnia
- Dizziness (Read More - Home Remedies for Dizziness: Quick Tips for Instant Relief)
- पेट की गैस
- Drowsiness
- Fever (Read More - Home remedies for fever)
- Chills
- Contact Dermatitis
- पेट दर्द
Otiflox 0.3%/0.025%/1% Ear Drop Related Warnings
-
Is the use of Otiflox 0.3%/0.025%/1% Ear Drop safe for pregnant women?
There are no side effects of Otiflox in pregnant women.
-
Is the use of Otiflox 0.3%/0.025%/1% Ear Drop safe during breastfeeding?
Otiflox does not show any side effects in breastfeeding women.
-
What is the effect of Otiflox 0.3%/0.025%/1% Ear Drop on the Kidneys?
Otiflox is not harmful for kidneys.
-
What is the effect of Otiflox 0.3%/0.025%/1% Ear Drop on the Liver?
Otiflox is completely safe for the liver.
-
What is the effect of Otiflox 0.3%/0.025%/1% Ear Drop on the Heart?
Otiflox is not harmful for the heart.
Severe Interaction of Otiflox 0.3%/0.025%/1% Ear Drop with Other Drugs
Otiflox 0.3%/0.025%/1% Ear Drop should not be taken with following medicines due to severe side effects it may cause to patients -
Life Threatening
Severe
Moderate
Mild
Otiflox 0.3%/0.025%/1% Ear Drop Contraindications
If you are suffering from any of the following diseases, you should not take Otiflox 0.3%/0.025%/1% Ear Drop unless your doctor advises you to do so -
- Atrial Fibrillation
- Heart Failure
- Calcium Deficiency
- Potassium Deficiency
- Thyroid problems
- Myasthenia Gravis
- Kidney Disease
- Diabetes
- Cushing's Syndrome
- Tuberculosis (TB)
- Infections
- Osteoporosis
- Liver Disease
- Depression
- Osteonecrosis
- Abdominal Pain
- Diabetes
- AIDS Dysmorphic Syndrome
Frequently asked Questions about Otiflox 0.3%/0.025%/1% Ear Drop
-
Is this Otiflox 0.3%/0.025%/1% Ear Drop habit forming or addictive?
No, there is no any evidence that Otiflox 0.3%/0.025%/1% Ear Drop is addictive.
Otiflox 0.3%/0.025%/1% Ear Drop Interactions with Food and Alcohol
-
Interaction between Food and Otiflox 0.3%/0.025%/1% Ear Drop
Taking Otiflox 0.3%/0.025%/1% Ear Drop with food does not cause any problems.
-
Interaction between Alcohol and Otiflox 0.3%/0.025%/1% Ear Drop
Consuming limited amounts of alcohol while taking Otiflox 0.3%/0.025%/1% Ear Drop does not cause any harmful effects. But it is best to observe caution.
See all substitutes for Otiflox
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1400
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 713
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Floxin® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ocuflox® (ofloxacin)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Qvar® Redihaler™ (beclomethasone dipropionate HFA)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-356
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; QVAR® (beclomethasone dipropionate HFA)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 174-177
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 763,792
